Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients
A Three Month Prospective Open Label Study of Therapy With Fragmin
(Dalteparin Sodium Injection) in Children With Venous Thromboembolism With or Without
Malignancies
Category & Conditions: Cardiovasular Diseases and Conditions
Medicine: FRAGMIN®(DALTEPARIN SODIUM INJECTION)
ClinicalTrials.gov Identifier (NCT): NCT00952380
Protocol ID: A6301094
Open Plain Language Summary Result:
Click here